CVS Group plc, a leading provider of integrated veterinary services in the UK, has announced that certain employees have exercised options under the CVS Group 2019 SAYE Plan. A total of 834 ordinary shares of 0.2 pence each were issued to satisfy the balance of ordinary shares arising from the exercise. These new shares have been admitted to the London Stock Exchange through the company's block listing. As a result, CVS Group now has a total issued share capital of 71,429,755 ordinary shares, each carrying one voting right. The company does not hold any ordinary shares in treasury.
Shareholders can use this figure as the denominator for calculating their notification requirements under the FCA's Disclosure Guidance and Transparency Rules. CVS Group's CEO, Richard Fairman, and Company Secretary, Scott Morrison, can be contacted for further information. Peel Hunt LLP and Berenberg are the company's nominated adviser, broker, and joint broker, respectively. Camarco is the company's financial PR firm.
CVS Group operates veterinary practices in the UK, Australia, the Netherlands, and the Republic of Ireland. The company is focused on providing high-quality clinical services to its customers and their animals. It has approximately 500 veterinary practices, including specialist referral hospitals and out-of-hours sites. CVS Group also operates laboratories, crematoria, buying groups, and an online retail business called "Animed Direct."